Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biologicals ; 83: 101695, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37516084

ABSTRACT

Regulatory authorities require veterinary batch-release testing to confirm vaccine potency and safety, but these tests have traditionally relied on large numbers of laboratory animals. Advances in vaccine research and development offer increasing opportunities to replace in vivo testing, and some stakeholders have made significant progress in incorporating 3Rs elements in quality control strategies. A three-part event series entitled "3Rs Implementation in Veterinary Vaccine Batch-Release Testing: Current state-of-the-art and future opportunities" was jointly organized by the Animal-Free Safety Assessment Collaboration, HealthforAnimals, and the International Alliance of Biological Standardization. Two webinars and a workshop aimed to outline the state-of-the-art non-animal approaches for veterinary batch-release testing. The events included information on the state of the deletion of obsolete safety testing and the current initiatives implemented by European, North American, and Asian-Pacific stakeholders on 3Rs implementation and regulatory acceptance. The events contributed to a better understanding of the barriers to 3Rs implementation. Participants highlighted the need for open communication, continued collaboration between stakeholders, and international harmonization of regulatory requirements to help accelerate acceptance. Despite the challenges, the countries represented at this three-part event have shared their commitments to advancing the acceptance of alternative methods.


Subject(s)
Vaccines , Humans , Animals , Quality Control , Vaccine Potency , Animal Testing Alternatives
2.
Dev Comp Immunol ; 51(1): 170-84, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25796577

ABSTRACT

A new member of the chicken TNF superfamily has recently been identified, namely receptor activator of NF-κB ligand (RANKL), as have its signalling receptor, RANK, and its decoy receptor, osteoprotegerin (OPG). In mammals, RANKL and RANK are transmembrane proteins expressed on the surface of Th1 cells and dendritic cells (DC) respectively, whereas OPG is expressed as a soluble protein from osteoblasts and DC. Recombinant soluble chicken RANKL (chRANKL) forms homotrimers whereas chicken OPG (chOPG) forms homodimers, characteristic of these molecules in mammals. ChRANKL, chRANK and chOPG are expressed at the mRNA level in most tissues and organs. ChRANKL is transcriptionally regulated by Ca(2+) mobilisation and enhances the mRNA expression levels of pro-inflammatory cytokines in bone marrow-derived DC (BMDC); this is inhibited by both chOPG-Fc and soluble chRANK-Fc. However, chRANKL does not enhance the expression of cell surface markers in either BMDC or BM-derived macrophages (BMM). Furthermore, chRANKL enhances the survival of APC similar to its mammalian orthologue.


Subject(s)
Avian Proteins/metabolism , Chickens/immunology , Dendritic Cells/immunology , Osteoblasts/immunology , Osteoprotegerin/metabolism , RANK Ligand/metabolism , Receptor Activator of Nuclear Factor-kappa B/metabolism , Th1 Cells/immunology , Animals , Avian Proteins/genetics , Biological Evolution , Calcium Signaling , Cell Survival , Conserved Sequence/genetics , Cytokines/metabolism , Inflammation Mediators/metabolism , Osteoprotegerin/genetics , RANK Ligand/genetics , Receptor Activator of Nuclear Factor-kappa B/genetics
3.
J Immunol ; 175(3): 1498-506, 2005 Aug 01.
Article in English | MEDLINE | ID: mdl-16034087

ABSTRACT

We observed a remarkable synergism of adenoviruses and LPS in triggering the production of TNF in intact animals. We found that in mice pre-exposed to adenoviruses, LPS injections generated extremely high levels of TNF with altered kinetics. The elevated TNF synthesis stemmed mostly from posttranscriptional up-regulation of TNF production, although transcription of the TNF gene was also induced. Adenoviruses and LPS exhibited a significant but less dramatic synergism in the induction of IL-6, IFN-gamma, and NO. Only marginal changes were detected in the synthesis of a panel of other cytokines. Different serotypes of the virus showed practically identical effects. As deletion mutants lacking indispensable viral genes or UV inactivated virions exhibited similar activities as the infectious, wild-type virus, it seems unlikely that the viral genome plays any significant role in the phenomenon. Published data indicate that other viruses also show some kind of synergism with LPS, although by different cellular mechanisms. T cells and their IFN-gamma production--crucial in the synergism of influenza viruses and LPS--were dispensable in our experiments. We suggest that the phenomenon is probably a general one: an overlap between different molecular mechanisms detecting bacterial and viral pathogens and inducing mediators of nonspecific cell-mediated host defense. The synergism of viruses and LPS (bacteria) could be a concern in medical practice as well as in gene therapy experiments with high doses of recombinant adenoviruses.


Subject(s)
Adenoviridae Infections/immunology , Lipopolysaccharides/toxicity , Shock, Septic/immunology , Shock, Septic/mortality , Tumor Necrosis Factor-alpha/biosynthesis , Up-Regulation/immunology , Adenoviridae Infections/blood , Adenoviridae Infections/metabolism , Animals , Capsid/metabolism , Cell Line , Cells, Cultured , Cytokines/biosynthesis , Cytokines/genetics , Dose-Response Relationship, Immunologic , Gene Expression Regulation, Viral/immunology , Humans , Injections, Intraperitoneal , Lipopolysaccharides/administration & dosage , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Nude , Nitric Oxide/biosynthesis , Organ Specificity/immunology , Serotyping , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation/genetics , Virion/immunology , Virus Activation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...